Movement Alert|Equifax Falls 11.74% in Regular Trading, Q2 Earnings Barely Beat Expectations While Q3 Guidance Misses Estimates

Market Focus
Yesterday

On July 21, Equifax declined 11.74% in regular trading, trading at $167.13/share, with turnover of $195 million. The sharp selloff was triggered by the company's Q2 earnings report showing only marginal beats alongside below-consensus Q3 guidance.

Equifax reported Q2 adjusted EPS of $2.25, beating the $2.20 consensus by just 2.3%, a stark deceleration from Q1's 9.4% earnings beat. Revenue came in at $1.70 billion versus the $1.696 billion estimate, representing 11% year-over-year growth. For Q3, the company guided adjusted EPS of $2.15-$2.25 and revenue of $1.68-$1.71 billion, both below analyst expectations of $2.26 EPS and $1.71 billion in revenue. Full-year guidance was narrowed to adjusted EPS of $8.39-$8.69 and revenue of $6.71-$6.78 billion, bracketing the FactSet estimate of $8.62 EPS on $6.77 billion revenue.

Additionally, Equifax announced an $825 million acquisition of Mexican credit bureau Circulo de Credito and doubled its AI-driven cost reduction target to $150 million, but these initiatives failed to offset investor concerns over decelerating growth momentum.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10